US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

No Surprises Act's New Rule Hands Win To Providers No Photo Available

Yeji Jesse Lee

A long-awaited update to the No Surprises Act includes technical changes to dispute resolutions that attorneys say add up to a win for... (more story)

3 State Drug Pricing Bills Attys Should Know No Photo Available

Gianna Ferrarin

State lawmakers continue to debate bills aimed at controlling the prices of prescription drugs. In recent weeks, high-profile bills in... (more story)

4 Things To Know Before Feds Fight Rhode Island's 340B Law No Photo Available

Mark Payne

With the federal government's support, drug companies will try to persuade the First Circuit on Wednesday to strike down a Rhode Islan... (more story)